Maxvoid 8 CP Tablet
Maxvoid 8 CP Tablet is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Maxvoid 8 CP Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Maxvoid 8 CP Tablet is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Maxvoid 8 CP Tablet is an alpha-adrenergic antagonist that is used in the treatment of benign prostatic hyperplasia. It helps to relieve symptoms like difficulty in passing urine. However, it does not decrease the size of the prostate.
Maxvoid 8 CP Tablet is advised to take it in a dose and duration as per prescription. It should be taken with food, but take at the same time regularly. Swallow the medicine as a whole without crushing or chewing it. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.Some common side effects of this medicine are retrograde ejaculation, dizziness, diarrhea, orthostatic hypotension, headache, nasopharyngitis, and nasal congestion. If any of the side effects persist or bother you, you must consult the doctor without delay.Simple lifestyle changes can help you manage your symptoms better. Try to urinate as soon as you feel the urge, however, never strain or push to empty your bladder. You should avoid drinking caffeinated or alcoholic drinks at night and a few hours before going to bed or going out.Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you have to undergo eye surgery due to cataracts or glaucoma then inform your eye doctor about the usage of this medicine. Patients with liver or kidney disease must be cautious while receiving the prescription, and they must receive regular follow-ups as per the doctor’s advice.
03Uses
Treatment of Benign prostatic hyperplasia
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Maxvoid 8 CP Tablet is to be taken with food.
05How It Works
Maxvoid 8 CP Tablet is an alpha blocker. It works by relaxing muscle around the bladder exit and prostate gland so urine is passed more easily.
06What If You Miss A Dose?
If you miss a dose of Maxvoid 8 CP Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
07Benefits
In Treatment of Benign prostatic hyperplasia
When your prostate gland becomes enlarged it can cause urinary problems such as difficulty passing urine and a need to go to the toilet frequently or urgently. It can also cause urine flow to be slower. If not treated, there is a risk that your urine flow will be completely blocked. Maxvoid 8 CP Tablet works by relaxing muscles in the bladder and prostate. So, it can rapidly relieve the symptoms and make it easier for you to urinate. However, it may take up to 6 months to notice the full benefit. Take this medicine exactly as prescribed for maximum benefits.
08Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Nasal congestion (stuffy nose)
Nasopharyngitis (inflammation of the throat and nasal passages)
Blurred vision
Headache
Orthostatic hypotension (sudden lowering of blood pressure on standing)
Diarrhea
Dizziness
Retrograde ejaculation
09Safety Information
Alcohol:UNSAFE
Maxvoid 8 CP Tablet may cause excessive drowsiness with alcohol.
Pregnancy:SAFE IF PRESCRIBED
Maxvoid 8 CP Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding:CONSULT YOUR DOCTOR
Information regarding the use of Maxvoid 8 CP Tablet during breastfeeding is not available. Please consult your doctor.Silodosin is not indicated for use in women.
Driving:CAUTION
Maxvoid 8 CP Tablet may cause dizziness or weakness due to low blood pressure. Do not drive if these symptoms occur.
Kidney:CAUTION
Maxvoid 8 CP Tablet should be used with caution in patients with kidney disease. Dose adjustment of Maxvoid 8 CP Tablet may be needed. Please consult your doctor.Use of Maxvoid 8 CP Tablet is not recommended in patients with severe kidney disease.
Liver:CAUTION
Maxvoid 8 CP Tablet should be used with caution in patients with severe liver disease. Dose adjustment of Maxvoid 8 CP Tablet may be needed. Please consult your doctor.Limited information is available on the use of Maxvoid 8 CP Tablet in these patients.
10Drug Tips
Maxvoid 8 CP Tablet helps in relieving the symptoms of enlarged prostate. It does not decrease the size of the prostate.
Maxvoid 8 CP Tablet must be taken with food.
You will feel better within hours or days of starting the treatment. Full effect is usually seen within 2 weeks.
Maxvoid 8 CP Tablet may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
If you are scheduled to undergo an eye surgery due to cataract or glaucoma, inform your eye doctor about the usage of Maxvoid 8 CP Tablet.
Inform your doctor if you have ever been diagnosed with kidney or liver problems.
References
Sources and references
Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 307.
Sildosin. Milan, Italy: Recordati Industria Chimica e Farmaceutica. view
Silodosin. Corona, California: Watson Laboratories, Inc; 2008 . view
Central Drugs Standard Control Organisation . view
